Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.


Diagnostic Dilemmas in Differentiating Unipolar and Bipolar Depression

In this episode, Leslie Citrome, MD, MPH, and Manpreet K. Singh, MD, MS, discuss diagnosing unipolar vs bipolar depression. They review why it can be difficult to differentiate between unipolar and bipolar depression; which screening tools they employ, including the rapid mood screener (RMS); how to reduce chances of missing mania; and special tips for differentiating between major depressive disorder (MDD) and bipolar depression in children.

Leslie Citrome, MD, MPH
Manpreet K. Singh, MD, MS
Released: August 20, 2021

Information on this Educational Activity


Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Leslie Citrome, MD, MPH, has disclosed that he has received consulting fees from AbbVie, Acadia, Alkermes, Allergan, Angelini, Astellas, Avanir, Axsome, BioXcel, Boehringer Ingelheim, Cadent Therapeutics, Eisai, Impel, Intra-Cellular Therapies, Janssen, Karuna, Lundbeck, Lyndra, Medavante-ProPhase, Merck, Neurocrine, Noven, Otsuka, Ovid, Relmada, Sage, Sunovion, and Teva; has received fees for non-CME/CE services from AbbVie, Acadia, Alkermes, Allergan, Angelini, Eisai, Intra-Cellular Therapies, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sunovion, Takeda, and Teva, and has ownership interest in Bristol-Myers Squibb, Johnson & Johnson, Lilly, Merck, and Pfizer.
Manpreet K. Singh, MD, MS

Associate Professor of Psychiatry and Behavioral Sciences
Stanford University
Stanford, California

Manpreet K. Singh, MD, MS, has disclosed that she has received funds for research support from Allergan and Johnson & Johnson and consulting fees from Limbix and Sunovion.

Program Medium

This program has been made available online.


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Intra-Cellular Therapies

Related Content

Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients

Thomas L. Schwartz, MD Released: October 15, 2021

Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)

Joseph F. Goldberg, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I (Preapproved) credit Released: October 7, 2021 Expired: October 6, 2022

Podcast from Clinical Care Options (CCO) with Dr. Joseph Goldberg and Dr. Greg Mattingly on the role of antidepressants in bipolar disorder

Joseph F. Goldberg, MD Greg Mattingly, MD Released: October 5, 2021

Slides from a presentation that educates clinicians on advances in the treatment of tardive dyskinesia (TD)

John M. Kane, MD Released: October 1, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.